Navigation Links
Bioheart, Inc. Announces Financial Results for Second Quarter 2008
Date:7/30/2008

Development revenues 15,000 - 76,500 -

Expenses:

Research and

development 1,477,634 1,785,661 2,835,691 3,186,251

Marketing, general

and administrative 1,876,442 873,300 2,948,711 1,750,676

Depreciation and

amortization 45,921 45,780 91,549 92,226

Total expenses 3,399,997 2,704,741 5,875,951 5,029,153

Loss from

operations (3,372,732) (2,536,793) (5,764,316) (4,854,760)

Interest income 8,256 75,157 42,202 115,781

Interest expense (496,875) (300,801) (1,430,285) (301,362)

Net interest

(expense) income (488,619) (225,644) (1,388,083) (185,581)

Loss before income

taxes (3,861,351) (2,762,437) (7,152,399) (5,040,341)

Income taxes - - - -

Net loss $(3,861,351) $(2,762,437) $(7,152,399) $(5,040,341)

Loss per share -

basic and diluted $(0.27) $(0.21) $(0.51) $(0.39)

Weighted average shares

outstanding - basic

and diluted 14,447,138 13,235,738 14,150,984 13,012,328

Contact: William Kline Lytham Partners, LLC

Chief Financial Officer Joe Diaz

Nicholas Burke Joe Dorame

VP - Financial Operations Robert Blum

(954) 835-1500 (602) 889-9700


'/>"/>
SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bioheart, Inc. to Report Full Year 2007 Financial Results on Thursday, March 27, 2008
2. Bioheart, Inc. Announces Financial Results for First Quarter 2008
3. Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
4. Bioheart, Inc. to Host Annual Meeting of Shareholders on Wednesday, July 30, 2008
5. Bioheart, Inc. to Transfer to Nasdaq Capital Market
6. Bioheart, Inc., Added to Russell Microcap Index
7. Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
8. Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
9. Bioheart, Inc., Announces Management Change
10. Bioheart, Inc. Announces Results of Annual Meeting
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...nce Call on Thursday, November 5, 2009 at 4:30 p.m...v. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceut...: OGXI ) today reported unaudited financial resul...tember 30, 2009 and reviewed the Company,s highlig...wing consolidated results reflect the operations o...
(Date:11/5/2009)...LE, Calif., Nov. 5 Cephe...tives will be speaking at the following investor c...ia webcast. , , Credit Suisse Heal...ursday, 12 November, 2009 at 10 a.m. Mountain Time...m, London, England, Tuesday, 1 Dec...
(Date:11/5/2009)..., Calif., Nov. 5 WaferGe...eading developer of state-of-the-art genetic analy...s, Ph.D. has joined the company,s Scientific Advis...ng and commercializing novel molecular diagnostics...on the development of computational biology system...
(Date:11/5/2009)... Drug safety specialty firm BioSoteria...d Informatics earned the Certified Professional in... from the American Society for Training and Develo...ewell has more than fifteen years of medical commu...is responsible for the development of the company,...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8Cepheid to Webcast Upcoming Financial Presentations 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4
...sdaq:,CPHD) announced today that the Company will ...-- The Robert W. Baird Growth Stock Conference on ...otel in Chicago, -- The Bank of America Healthcar... Four Seasons Hotel in Las Vegas, John Bishop, Ch...ice,President, Chief Financial Officer, will provi...
... and some clever chemistry, University of Californ...rk fish whose internal light comes from the sugar ...uorescently tagging the sugar chains, or carbohydr...ying development in the zebrafish, a laboratory or...ow easy observation of living cells as they develo...
...d pharma companies,are increasingly utilizing nove...compounds early in the development cycle to avoid ... Genetic Engineering and,Biotechnology News (GEN) ...orption, distribution, metabolism, excretion, and ... opportunity to increase the probability,of succes...
Other Biology Technology:Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference 2Glowing zebrafish help researchers track role of sugars in the cell 2Glowing zebrafish help researchers track role of sugars in the cell 3Genetic Engineering and Biotechnology News (GEN) Reports on Early ADMET Use 2
(Date:11/4/2009)...wswire/ -- GenVault Corporation (Carlsbad, CA) tod...joined its Board of Directors. Dr. Brody, the Irw..., is an acclaimed physician-scientist and universi...r. Brody served as president of The Johns Hopkins ...y of Engineering and the Institute of Medicine, an...
(Date:11/3/2009)...e loner of the ocean, cruising thousands of miles ...discovered that the sharks have maintained such a ...thousands of years the white sharks in the northea... a population genetically distinct from sharks els..., highly mobile species," said Salvador Jorgensen,...
(Date:11/3/2009)...Chief executives in 35 of the top Fortune 500 comp...l salaries" in 2008, according to a new type of th... researcher to determine fair CEO compensation. ,... governance issues of the day is how to determine ...bramanian, a professor of chemical engineering. "T...
Breaking Biology News(10 mins):Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4Renal Physicians Association Participates in PEAK Campaign 50406 1Accumetrics Inc Announces GRAVITAS Trial 50 Percent Enrolled 4670 1Accumetrics Inc Announces GRAVITAS Trial 50 Percent Enrolled 4670 2First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 1First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 2First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 3First Book Focusing on How 26quot 3BThe Secret Pain Women Won 26apos 3Bt Talk About 26quot 3B Affects Relationships 50404 4
... Department of Energys Office of Science today rel...publication, Facilities for the Future of Science:...made significant progress in deploying the scienti...tes needs to capture world scientific leadership, ...partments missions. , When it was published four ...
...One of the World,s Leading Software ..., Oct. 10 (OTC Bulletin,Board: CICI) Communicatio...lier of electronic signature solutions for busines... the recognized leader in biometric signature,veri...rd time in Software,Magazine,s Software 500 rankin...
...angladesh finds that folic acid supplements can dr...ls chronically exposed to arsenic-contaminated dri...aturally present in some soils and water. Arsenic...icant public health problem in at least 70 countri...o parts of the United States. Chronic arsenic exp...
Other Biology News:DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 2DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 3DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 4DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 5CIC Again Named to Software Magazine's Annual Prestigious Software 500 List 2CIC Again Named to Software Magazine's Annual Prestigious Software 500 List 3Folic acid lowers blood arsenic levels in Bangladesh 2Folic acid lowers blood arsenic levels in Bangladesh 3
Mouse Anti-Human MOC31 Monoclonal Antibody, Unconjugated from AbD Serotec
Goat Anti-Human LAIR2 Polyclonal Antibodies, Biotin Conjugated from R&D Systems
Incomplete Adjuvant from Santa Cruz Biotechnology, Inc.
...acks the mycobacteria found in Complete Freund's A... reason, Incomplete, Freund's Adjuvant is used ...e used to produce water-in-oil emulsions of immuno...te high and long-lasting antibody responses which ...
Biology Products: